ReviewAnimals : an open access journal from MDPI2022
Monkeypox: Some Keys to Understand This Emerging Disease.
Review in Animals : an open access journal from MDPI, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed.
- Pathogenicity and transmissibility of Mpox virus in African dormice.Microbiology spectrum · 2026Article
- Clinical manifestations and pathogenicity of Clade IIb monkeypox virus in rabbits.Emerging microbes & infections · 2025Article
- Advancing Infectious Diseases Control in Africa: Lessons From the Mpox Re-emergence.Health science reports · 2025Article
- Comprehensive Genomic, Mutation, Phylogenetic, and Statistical Analysis of the Monkeypox Virus Across Multiple Countries.Indian journal of microbiology · 2025Article
- The resurgence of monkeypox clade Ib: a global health emergency and concern.Archives of virology · 2025Review
- Evolutionary variation of the monkeypox virus detected for the first time in Nantong, Jiangsu.Virology journal · 2024Article
- Navigating monkeypox: identifying risks and implementing solutions.Open veterinary journal · 2024Review
- Exploring Monkeypox: prospects for therapeutics through computational-aided drug discovery.Molecular diversity · 2024Review
- A Review of Evidence Related to the Zoonotic Characteristics of the Monkeypox Virus.Open forum infectious diseases · 2024Article
- Computational investigations of potential inhibitors of monkeypox virus envelope protein E8 through molecular docking and molecular dynamics simulations.Scientific reports · 2024Article
- A bioinformatics approach to systematically analyze the molecular patterns of monkeypox virus-host cell interactions.Heliyon · 2024Article
- Clade Ib: a new emerging threat in the Mpox outbreak.Frontiers in pharmacology · 2024Review
- Review
- A multi-targeted computational drug discovery approach for repurposing tetracyclines against monkeypox virus.Scientific reports · 2023Article
- Safety of Monkeypox Vaccine Using Active Surveillance, Two-Center Observational Study in Italy.Vaccines · 2023Article
- Stigmatizing Monkeypox and COVID-19: A Comparative Framing Study ofInternational journal of environmental research and public health · 2023Article
- Metabolism Pathways of Major Therapeutics for Treating Monkeypox Mono- and Co-infection with Human Immunodeficient Virus or SARS-CoV-2.Current drug metabolism · 2023Review
- The re-emergence and transmission of Monkeypox virus in Nigeria: the role of one health.Frontiers in public health · 2023Article
- Preventing monkeypox outbreaks: Focus on diagnosis, care, treatment, and vaccination.Journal of clinical and translational science · 2023Review
- Monkeypox Disease with a Focus on the 2022 Outbreak; a Narrative Review.Archives of academic emergency medicine · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In 1958, several monkeys in a Copenhagen laboratory developed a skin rash from which an orthopoxvirus could be isolated, which was named monkeypox virus (MPXV). However, the natural animal reservoir for MPXV is thought to be a rodent. The first human case occurred in 1970, and the incidence has increased progressively throughout the years. Starting May 2022, the number of cases outside Africa has soared, especially in Western Europe. There are two clades of MPXV, Congo Basin, with higher virulence and mortality, and Western Africa (WA). MPXV from the present outbreak has been proposed to be classified as Clade 3, distinct from the WA clade by at least 50 substitutions, which may increase human-to-human transmissibility. Most cases correspond to men in their 30s who have sex with men, and the possibility of sexual transmission is under investigation. Though there is no evidence of human-to-animal transmission, pets of positive human cases may be classified as low risk, including dogs, cats, and birds, who can be quarantined at home, and high risk, such as pet rabbits or mice, who should be isolated in official laboratories for observation. The current epidemiological data do not support the risk of a pandemic.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.